Biology Reference
In-Depth Information
88. Kapsimali M, Kloosterman WP, de Bruijn E,
Rosa F, Plasterk RH, Wilson SW (2007)
MicroRNAs show a wide diversity of expres-
sion profi les in the developing and mature
central nervous system. Genome Biol 8:R173
89. Dogini DB, Ribeiro PA, Rocha C, Pereira TC,
Lopes-Cendes I (2008) MicroRNA expres-
sion profi le in murine central nervous system
development. J Mol Neurosci 35:331-337
90. Bak M, Silahtaroglu A, Moller M, Christensen
M, Rath MF, Skryabin B, Tommerup N,
Kauppinen S (2008) MicroRNA expression in
the adult mouse central nervous system. RNA
14:432-444
91. Pillai RS (2005) MicroRNA function: multi-
ple mechanisms for a tiny RNA? RNA
11:1753-1761
92. Filipowicz W, Jaskiewicz L, Kolb FA, Pillai RS
(2005) Post-transcriptional gene silencing by
siRNAs and miRNAs. Curr Opin Struct Biol
15:331-341
93. van den Berg A, Mols J, Han J (2008) RISC-
target interaction: cleavage and translational
suppression.
vectors with very broad host range. Methods
Cell Biol 43(Pt A):99-112
101. Klages N, Zufferey R, Trono D (2000) A
stable system for the high-titer production of
multiply attenuated lentiviral vectors. Mol
Ther 2:170-176
102. Sparacio S, Pfeiffer T, Schaal H, Bosch V
(2001) Generation of a fl exible cell line with
regulatable, high-level expression of HIV
Gag/Pol particles capable of packaging HIV-
derived vectors. Mol Ther 3:602-612
103. Ikeda Y, Takeuchi Y, Martin F, Cosset FL,
Mitrophanous K, Collins M (2003)
Continuous high-titer HIV-1 vector produc-
tion. Nat Biotechnol 21:569-572
104. Cockrell AS, Ma H, Fu K, McCown TJ, Kafri
T (2006) A trans-lentiviral packaging cell line
for high-titer conditional self-inactivating
HIV-1 vectors. Mol Ther 14:276-284
105. Broussau S, Jabbour N, Lachapelle G,
Durocher Y, Tom R, Transfi guracion J,
Gilbert R, Massie B (2008) Inducible packag-
ing cells for large-scale production of lentivi-
ral vectors in serum-free suspension culture.
Mol Ther 16:500-507
106. Yang S, Delgado R, King SR, Woffendin C,
Barker CS, Yang ZY, Xu L, Nolan GP, Nabel
GJ (1999) Generation of retroviral vector for
clinical studies using transient transfection.
Hum Gene Ther 10:123-132
107. Farson D, Witt R, McGuinness R, Dull T, Kelly
M, Song J, Radeke R, Bukovsky A, Consiglio
A, Naldini L (2001) A new-generation stable
inducible packaging cell line for lentiviral vec-
tors. Hum Gene Ther 12:981-997
108. Sastry L, Johnson T, Hobson MJ, Smucker B,
Cornetta K (2002) Titering lentiviral vectors:
comparison of DNA, RNA and marker expres-
sion methods. Gene Ther 9:1155-1162
109. Paxinos G, Watson C, Pennisi M, Topple A
(1985) Bregma, lambda and the interaural
midpoint in stereotaxic surgery with rats of
different sex, strain and weight. J Neurosci
Methods 13:139-143
110. Messier C, Emond S, Ethier K (1999) New
techniques in stereotaxic surgery and anesthe-
sia in the mouse. Pharmacol Biochem Behav
63:313-318
111. Kato S, Kobayashi K, Inoue K, Kuramochi M,
Okada T, Yaginuma H, Morimoto K, Shimada
T, Takada M (2011) A lentiviral strategy for
highly effi cient retrograde gene transfer by
pseudotyping with fusion envelope glycopro-
tein. Hum Gene Ther 22:197-206
112. Kato S, Kuramochi M, Takasumi K, Kobayashi
K, Inoue K, Takahara D, Hitoshi S, Ikenaka
K, Shimada T, Takada M (2011) Neuron-
specifi c gene transfer through retrograde
transport of lentiviral vector pseudotyped
with a novel type of fusion envelope glycopro-
tein. Hum Gene Ther 22:1511-1523
Biochim
Biophys
Acta
1779:668-677
94. Regulier E, Zala D, Aebischer P, Deglon N
(2004) Lentiviral-mediated gene transfer to
model triplet repeat disorders. Methods Mol
Biol 277:199-213
95. Kutner RH, Zhang XY, Reiser J (2009)
Production, concentration and titration of
pseudotyped HIV-1-based lentiviral vectors.
Nat Protoc 4:495-505
96. Segura MM, Garnier A, Durocher Y, Ansorge
S, Kamen A (2010) New protocol for lentivi-
ral vector mass production. Methods Mol
Biol 614:39-52
97. Lesch HP, Laitinen A, Peixoto C, Vicente T,
Makkonen KE, Laitinen L, Pikkarainen JT,
Samaranayake H, Alves PM, Carrondo MJ,
Yla-Herttuala S, Airenne KJ (2011)
Production and purifi cation of lentiviral vec-
tors generated in 293T suspension cells with
baculoviral vectors. Gene Ther 18:531-538
98. Merten OW, Charrier S, Laroudie N,
Fauchille S, Dugue C, Jenny C, Audit M,
Zanta-Boussif MA, Chautard H, Radrizzani
M, Vallanti G, Naldini L, Noguiez-Hellin P,
Galy A (2011) Large-scale manufacture and
characterization of a lentiviral vector pro-
duced for clinical ex vivo gene therapy appli-
cation. Hum Gene Ther 22:343-356
99. Burns JC, Friedmann T, Driever W,
Burrascano M, Yee JK (1993) Vesicular sto-
matitis virus G glycoprotein pseudotyped ret-
roviral vectors: concentration to very high
titer and effi cient gene transfer into mamma-
lian and nonmammalian cells. Proc Natl Acad
Sci USA 90:8033-8037
100. Yee JK, Friedmann T, and Burns JC (1994)
Generation of high-titer pseudotyped retroviral
Search WWH ::




Custom Search